PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression.

"Declarations Ethics approval and consent to participateAll experiments were approved by the Ethics Committee at the Jiangxi Provincial People's Hospital (Approval Number: KT2023-016). Consent for publicationNot applicable. Competing interestsThe authors declare that they have no conflict of interest. Competing interests The authors declare that they have no conflict of interest."

"Funding This work is supported by grants from the National Natural Science Foundation of China (No. 82203342), the Jiangxi Provincial Natural Science Foundation (Nos. 20232ACB216013, 20224BAB216073 and 20212BAB216059), the Science and Technology Research Project of Jiangxi Provincial Department of Education (No. GJJ218906), and the Foundation of Health Care Rejuvenation by Science and Education (No. KJXW2022002)."